SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Venus Remedies - Quaterly Results

14 Feb 2024 Evaluate
The December 2023 quarter revenue stood at Rs. 1312.30 millions, up 19.90% as compared to Rs. 1094.50 millions during the corresponding quarter last year.Net Profit for the quarter ended December 2023 zoomed to 213.79% from Rs. 26.10 millions to Rs. 81.90  millions.The company reported a good operating profit of 154.20 millions compared to 108.30 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1312.30 1094.50 19.90 4000.50 3891.30 2.81 5376.60 5767.10 -6.77
Other Income 24.20 37.50 -35.47 74.10 69.30 6.93 101.70 84.30 20.64
PBIDT 154.20 108.30 42.38 470.10 474.30 -0.89 717.00 772.50 -7.18
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBDT 154.20 108.30 42.38 470.10 474.30 -0.89 717.00 772.50 -7.18
Depreciation 63.00 69.70 -9.61 198.30 233.10 -14.93 313.70 325.80 -3.71
PBT 91.20 38.60 136.27 271.80 241.20 12.69 403.30 446.70 -9.72
TAX 9.30 12.50 -25.60 92.00 26.90 242.01 113.70 -43.20 -363.19
Deferred Tax 11.60 12.50 -7.20 23.60 26.90 -12.27 113.70 -43.20 -363.19
PAT 81.90 26.10 213.79 179.80 214.30 -16.10 289.60 489.90 -40.89
Equity 133.70 133.70 0.00 133.70 133.70 0.00 133.70 133.70 0.00
PBIDTM(%) 11.75 9.89 18.75 11.75 12.19 -3.59 13.34 13.39 -0.44

Venus Remedies Share Price

1042.35 3.25 (0.31%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×